Literature DB >> 3493933

Pathophysiology of diarrhea in patients with familial amyloid neuropathy.

G E Feurle.   

Abstract

Seven patients with familial amyloid neuropathy (AF amyloidosis) were studied to clarify the pathophysiology of the diarrhea associated with this disorder. Fecal weight and fat determinations, 14C-glycocholate breath tests, and a test of B12 absorption were performed before and after treatment with co-trimoxazole. Gastric emptying was assessed with conventional roentgen contrast medium and radio-opaque markers. Gastric emptying was delayed, fecal weight and fat excretion increased, and the 14C-glycholate breath test abnormal in all but one patient. In most cases co-trimoxazole reduced diarrhea, steatorrhea, and 14C-glycine deconjugation; vitamin B12 absorption returned to normal in one patient after co-trimoxazole treatment. In a jejunal mucosal biopsy specimen, amyloid was absent in the villi, but small deposits were detected along small vessels and nerves in the lamina propria. These findings suggest altered gastrointestinal motility due probably to an autonomic neuropathy which in turn leads to enteral bacterial overgrowth and subsequently to diarrhea and steatorrhea. This diarrhea can be temporarily alleviated by co-trimoxazole treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3493933     DOI: 10.1159/000199393

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  5 in total

1.  Association of secondary amyloidosis with common variable immune deficiency and tuberculosis.

Authors:  Aykut Ferhat Celik; Mehmet Riza Altiparmak; Gülsüm Emel Pamuk; Omer Nuri Pamuk; Fehmi Tabak
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

2.  Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells.

Authors:  M el-Salhy; O Suhr; R Stenling; E Wilander; L Grimelius
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

3.  Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis.

Authors:  T Matsumoto; M Iida; M Hirakawa; K Hirakawa; F Kuroki; S Lee; T Nanbu; M Fujishima
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199

Review 4.  Systemic amyloidosis and the gastrointestinal tract.

Authors:  Prayman T Sattianayagam; Philip N Hawkins; Julian D Gillmore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

Review 5.  Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.

Authors:  Laura Obici; Ole B Suhr
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.